“We can confidently say that we will be able to vaccinate the entire population from covid-19 by the end of next year”, — such opinion was expressed by Director General and Chairman of the Board “Nanolek” Mikhail Nekrasov, speaking at an online conference “the Russian pharmaceutical sector in the context of the global pandemic”.
The duration of the development of a vaccine is at least 1.5-2 years, said Nekrasov. During this time the drug is necessary not only to create (to develop, conduct clinical studies and to register), but develop to the extent necessary. For example, 70 million doses of influenza vaccine in the company “Nanolek” accumulating during the year.
Nekrasov said that vaccine production always occurs on a full cycle and cannot happen apart from production of substance to her. “Not in one place to produce the substance, and the other the finished vaccine. They should be in a single technological chain,” he said.
To provide vaccines to the entire population of the country required the efforts of several immunobiological companies, said the speaker. Cooperation of scientific centres and production sites will help to provide the Russian market of drugs for a full cycle. As an example, M. Nekrasov led the successful cooperation of the company “Nanolek” and the Federal research centre for research and development of immunological products to them. M. P. Chumakov Russian Academy of Sciences.